嘧啶-5-甲醛 | 10070-92-5

• 物质功能分类: 医药中间体 - 杂环化合物 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 嘧啶-5-甲醛
• 中文别名: 5-醛基嘧啶；5-嘧啶甲醛
• 英文名称: pyrimidine-5-carbaldehyde
• 英文别名: pyrimidine-5-carboxaldehyde；5-pyrimidinecarboxaldehyde；5-formylpyrimidine；pyrimidin-5-carboxaldehyde；pyrimidine-5-formaldehyde
• CAS: 10070-92-5
• 化学式: C₅H₄N₂O
• 分子量: 108.1
• InChiKey: FREJAOSUHFGDBW-UHFFFAOYSA-N

物化性质

• 熔点：
  39-43°C
• 沸点：
  80-82°C 4mm
• 密度：
  1.23

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42.8
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn,Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2933599090
• 危险类别：
  IRRITANT
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  | 室温 |

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Pyrimidine-5-carboxaldehyde
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H315: Causes skin irritation
H317: May cause an allergic skin reaction
H319: Causes serious eye irritation
May cause respiratory irritation
H335:
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Pyrimidine-5-carboxaldehyde
Ingredient name:
CAS number: 10070-92-5

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H4N2O
Molecular weight: 108.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

嘧啶-5-甲醛是一种常用的有机合成基础原料和药物分子合成中间体，在有机合成中具有广泛的应用。该物质常被用于合成其他嘧啶类衍生物。作为重要的芳香化合物，嘧啶广泛存在于生物体内，尤其是在核酸（如DNA和RNA）的结构中。嘧啶及其衍生物在生物学中扮演着关键角色，是构建遗传信息和调节生物过程的重要组成部分。

嘧啶-5-甲醛作为一种嘧啶的衍生物，可用于合成更复杂的嘧啶类化合物。通过多种反应，它可以进行进一步的官能团转化，例如亲核加成、氨基化、羟基化以及取代反应等。这些反应能够引入不同官能团，从而扩展化合物的化学多样性和活性。

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  5-嘧啶甲醇	5-(hydroxymethyl)pyrimidine	25193-95-7	C5H6N2O	110.115

• 下游产品

  中文名称	英文名称	CAS号	化学式	分子量
  5-乙酰基嘧啶	1-(pyrimidin-5-yl)ethanone	10325-70-9	C6H6N2O	122.126
  5-氯甲基嘧啶	5-(chloromethyl)pyrimidine	101346-02-5	C5H5ClN2	128.561
  5-嘧啶甲胺	pyrimidin-5-ylmethanamine	25198-95-2	C5H7N3	109.131
  5-嘧啶甲醇	5-(hydroxymethyl)pyrimidine	25193-95-7	C5H6N2O	110.115

反应信息

• 作为反应物：
  描述：

  嘧啶-5-甲醛 在 盐酸羟胺 、 sodium hydroxide 作用下， 以 乙醇 为溶剂， 以70%的产率得到pyrimidine-5-carbaldehyde oxime
  参考文献：
  名称：

  [EN] SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS
  [FR] COMPOSÉS SPIRO-OXADIAZOLINE EN TANT QU'AGONISTES DES RÉCEPTEURS DE L'ACÉTYLCHOLINE Α-7 NICOTINIQUE

  摘要：

  本发明涉及新型螺环-噁二唑啉化合物，适用作a7-nAChR的激动剂或部分激动剂，以及这些化合物和组合物的制备方法、药物组合物，以及在维持、治疗和/或改善认知功能的方法中使用这些化合物和组合物。具体而言，涉及向需要的患者（例如患有认知缺陷和/或希望增强认知功能的患者）施用螺环-噁二唑啉cx7-nAChR激动剂或部分激动剂的方法，以使其获益。

  公开号：

  WO2015066371A1
• 作为产物：
  描述：

  甲酸乙酯 在 正丁基锂 、 盐酸 作用下， 以 四氢呋喃 、 乙醚 为溶剂， 反应 2.5h， 生成 嘧啶-5-甲醛
  参考文献：
  名称：

  6-O-substituted erythromycin derivatives having improved gastrointestinal tolerance

  摘要：

  具有化学式（I）的化合物可用于治疗细菌感染，同时避免胃肠不耐受的风险。含有这些化合物的组合物以及使用这些化合物进行治疗的方法也被揭示。

  公开号：

  US20060166906A1

文献信息

• [EN] HETEROARYL INHIBITORS OF PAD4<br/>[FR] INHIBITEURS HÉTÉROARYLES DE PAD4
  申请人：PADLOCK THERAPEUTICS INC

  公开号：WO2018049296A1

  公开（公告）日：2018-03-15

  The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.

  本发明提供了作为PAD4抑制剂有用的化合物，其组合物以及治疗与PAD4相关疾病的方法。
• [EN] cGAS ANTAGONIST COMPOUNDS<br/>[FR] COMPOSÉS ANTAGONISTES DU CGAS
  申请人：IMMUNE SENSOR LLC

  公开号：WO2017176812A1

  公开（公告）日：2017-10-12

  Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

  揭示了一种新型化合物的化学式（I），这些化合物是cGAS拮抗剂，涉及到这些化合物的制备方法、包含这些化合物的药物组合物，以及它们在医学治疗中的应用。
• Piperidinylamino-thieno[2,3-D] pyrimidine compounds
  申请人：Dhanoa S. Dale

  公开号：US20050222176A1

  公开（公告）日：2005-10-06

  The invention relates to 5-HT receptor modulators, particularly 5-HT 2B antagonists. Novel piperidinylamino-thieno [2,3-d] pyrimidine compounds represented by Formula I, II and III, and uses thereof for treating conditions including pulmonary arterial hypertension, congestive heart failure, and hypertension.

  这项发明涉及5-HT受体调节剂，特别是5-HT 2B 拮抗剂。公式I、II和III所代表的新型哌啶基氨基噻吩[2,3-d]嘧啶化合物，以及它们用于治疗包括肺动脉高压、充血性心力衰竭和高血压等疾病的用途。
• <i>N</i> -Arylamines Coupled with Aldehydes, Ketones, and Imines by Means of Photocatalytic Proton-Coupled Electron Transfer
  作者：Qing Xia、Hao Tian、Jianyang Dong、Yi Qu、Lili Li、Hongjian Song、Yuxiu Liu、Qingmin Wang

  DOI：10.1002/chem.201801886

  日期：2018.7.2

  A photoredox‐catalyzed umpolung strategy for coupling reactions between aldehydes, ketones, imines, and N‐arylamines is reported. These reactions proceed by a Brønsted acid‐activated proton‐coupled electron transfer pathway, and the protocol was used to synthesize a broad scope of 1,2‐amino alcohols and vicinal diamines, both of which are common motifs in biologically active natural products, pharmaceutically

  报道了一种光氧化还原催化的酚醛策略，用于醛，酮，亚胺和N-芳基胺之间的偶联反应。这些反应通过布朗斯台德酸活化的质子耦合电子转移途径进行，该方案用于合成范围广泛的1,2-氨基醇和邻二胺，这两种都是生物活性天然产物，药学上常见的基序。活性分子和配体。
• METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt
  申请人：Janssen Pharmaceutica NV

  公开号：US20150105366A1

  公开（公告）日：2015-04-16

  The present invention comprises compounds of Formula I. wherein: R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.

  本发明包括式I的化合物。 其中： R1、R2、R3、R4、R5、R6、R7、R8和R9在说明书中定义。 本发明还包括治疗或改善综合征、紊乱或疾病的方法，其中所述综合征、紊乱或疾病为类风湿性关节炎或银屑病。本发明还包括通过给予治疗有效量的至少一个权利要求1的化合物，来调节哺乳动物中RORγt活性的方法。